Emergent BioSolutions (EBS) Market Capitalization (2010 - 2026)
Emergent BioSolutions' Market Capitalization was $338.58 million in Q3 2026, down 27.2% from $464.81 million a year earlier and down 21.2% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Market Capitalization (2010 - 2026) Analysis & Trends
For FY2025, Market Capitalization at Emergent BioSolutions came in at $643.96 million, up 24.1% from FY2024.
- Market Capitalization shows a five-year compound annual growth rate of -33.0% (FY2020 to FY2025).
- In earlier years, Market Capitalization was $519.11 million in FY2024 (+314.4%), $125.28 million in FY2023 (-78.8%), $591.68 million in FY2022 (-73.5%) and $2.23 billion in FY2021 (-53.1%).
- The Q3 2026 figure marks the lowest quarterly Market Capitalization since Q1 2025.
- Compared with a year earlier, Market Capitalization was higher in six of the last eight quarters, with growth averaging 62.1%.
- The best year-over-year quarter for Market Capitalization over five years was Q4 2024 (growth of 314.4%); the worst was Q3 2023 (a decline of 83.2%).
- Per Business Quant data, EBS's Market Capitalization in the three quarters before Q3 2026 was $429.89 million (Q2 2026), $429.94 million (Q1 2026) and $643.96 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 338.58 Mn |
| Jun 30, 2026 | 429.89 Mn |
| Mar 31, 2026 | 429.94 Mn |
| Dec 31, 2025 | 643.96 Mn |
| Sep 30, 2025 | 464.81 Mn |
| Jun 30, 2025 | 342.61 Mn |
| Mar 31, 2025 | 264.87 Mn |
| Dec 31, 2024 | 519.11 Mn |
| Sep 30, 2024 | 451.74 Mn |
| Jun 30, 2024 | 360.78 Mn |
| Mar 31, 2024 | 132.57 Mn |
| Dec 31, 2023 | 125.28 Mn |
| Sep 30, 2023 | 176.12 Mn |
| Jun 30, 2023 | 380.73 Mn |
| Mar 31, 2023 | 522.14 Mn |
| Dec 31, 2022 | 591.68 Mn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 1.55 Bn |
| Mar 31, 2022 | 2.07 Bn |
| Dec 31, 2021 | 2.23 Bn |
API Access
Emergent BioSolutions Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();